Polaris Group

NT$13.70As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6550Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (16.29%)
Div yield —
ROE (81.10%)
Biotechnology
Beta (5Y) 0.70
PE TTM —
TSR TTM (79.25%)
Mkt cap NT$6.368B
ROIC (21.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$14
4.27%
(26.64%)
Hold 10|6|2|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.19
0.18
0.20
0.20
7.46%
(3.57%)
10.18%
5.85%
RevenueNT$M
669.1
696.9
690.7
679.0
3.25%
8.25%
1.93%
0.29%
Peers (US$192.3M)
Cap (US$)
PE
192.9M
—
184.3M
5.939x
192.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.864
(0.109)
(0.109)
EBIT/Intx
0.609
0.048
0.048
Own earn%
239.28
(5.18)
(27.85)
Sh yield%
24.67
30.14
27.23
Owners
Insiders/Inst%
3.04
20.18
Short interest%
0.91
SBC / revenue%
3.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
14–20
$1 testx
−2.2
Incr. ROIC%
3